Lysine-specific demethylase 1 (LSD1) destabilizes p62 and inhibits autophagy in gynecologic malignancies

43Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Lysine-specific demethylase 1 (LSD1) - also known as KDM1A - is the first identified histone demethylase. LSD1 is highly expressed in numerous human malignancies and has recently emerged as a target for anticancer drugs. Owing to the presence of several functional domains, we speculated that LSD1 could have additional functions other than histone demethylation. P62 - also termed sequestasome 1 (SQSTM1) - plays a key role in malignant transformation, apoptosis, and autophagy. Here, we show that a high LSD1 expression promotes tumorigenesis in gynecologic malignancies. Notably, LSD1 inhibition with either siRNA or pharmacological agents activates autophagy. Mechanistically, LSD1 decreases p62 protein stability in a demethylation-independent manner. Inhibition of LSD1 reduces both tumor growth and p62 protein degradation in vivo. The combination of LSD1 inhibition and p62 knockdown exerts additive anticancer effects. We conclude that LSD1 destabilizes p62 and inhibits autophagy in gynecologic cancers. LSD1 inhibition reduces malignant cell growth and activates autophagy. The combinations of LSD1 inhibition and autophagy blockade display additive inhibitory effect on cancer cell viability. A better understanding of the role played by p62 will shed more light on the anticancer effects of LSD1 inhibitors.

References Powered by Scopus

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

3561Citations
N/AReaders
Get full text

Self-eating and self-killing: Crosstalk between autophagy and apoptosis

3201Citations
N/AReaders
Get full text

How to interpret LC3 immunoblotting

2246Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>

1709Citations
N/AReaders
Get full text

Targeting epigenetic regulators to overcome drug resistance in cancers

123Citations
N/AReaders
Get full text

LSD1: more than demethylation of histone lysine residues

121Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Chao, A., Lin, C. Y., Chao, A. N., Tsai, C. L., Chen, M. Y., Lee, L. Y., … Wang, H. S. (2017). Lysine-specific demethylase 1 (LSD1) destabilizes p62 and inhibits autophagy in gynecologic malignancies. Oncotarget, 8(43), 74434–74450. https://doi.org/10.18632/oncotarget.20158

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

83%

Professor / Associate Prof. 1

17%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 5

71%

Medicine and Dentistry 1

14%

Immunology and Microbiology 1

14%

Save time finding and organizing research with Mendeley

Sign up for free